An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. (2017)
Attributed to:
Phenotyping and Experimental Medicine Centre for naturally occurring Gene Knock-Outs in Humans
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aan2514
PubMed Identifier: 29021166
Publication URI: http://europepmc.org/abstract/MED/29021166
Type: Journal Article/Review
Volume: 9
Parent Publication: Science translational medicine
Issue: 411
ISSN: 1946-6234